Intercept Pharma Q4 2021 Earnings Preview

• Intercept Pharma (NASDAQ:ICPT) is scheduled to announce Q4 earnings results on Wednesday, Mar. 2, before market open.
• The consensus EPS estimate is -$0.81 and the consensus revenue estimate is $92.09M (+10.7% Y/Y).
• Over the last 1 year, ICPT has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time.
• SA contributor Biotech Enthusiast recently wrote "Intercept Might Be An Intriguing Turn-Around Story", rating the stock Buy.